• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,137.53 334.63
( 0.44%)
Global Indices
Nasdaq
51,585.70 72.15
(0.14%)
Dow Jones
7,521.58 80.48
(1.08%)
Hang Seng
72,454.13 1,204.07
(1.69%)
Nikkei 225
10,357.71 -41.99
(-0.40%)
Forex
USD-INR
94.39 -0.12
(-0.13%)
EUR-INR
108.40 -1.03
(-0.94%)
GBP-INR
125.08 -1.43
(-1.13%)
JPY-INR
0.59 0.00
(-0.50%)

EQUITY - MARKET SCREENER

Mankind Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543904
INE634S01028
397.024678
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MANKIND
47.05
99835.58
EPS(TTM)
Face Value()
Div & Yield %
51.38
1
0.04
 

puravankara ltd
Hemang Resources reports standalone net loss of Rs 0.56 crore in the March 2026 quarter
May 28,2026
Net loss of Hemang Resources reported to Rs 0.56 crore in the quarter ended March 2026 as against net profit of Rs 0.77 crore during the previous quarter ended March 2025. Sales declined 9.16% to Rs 6.84 crore in the quarter ended March 2026 as against Rs 7.53 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.43 crore in the year ended March 2026 as against net profit of Rs 0.54 crore during the previous year ended March 2025. Sales declined 8.18% to Rs 8.08 crore in the year ended March 2026 as against Rs 8.80 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales6.847.53 -9 8.088.80 -8
OPM %-9.808.23 --16.71-1.02 -
PBDT-0.681.09 PL -0.550.87 PL
PBT-0.681.09 PL -0.550.86 PL
NP-0.560.77 PL -0.430.54 PL